pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3607 |
Genomic Coordinates | chr5: 86620497 - 86620575 |
Description | Homo sapiens miR-3607 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | hsa-miR-3607-3p |
Sequence | 51| ACUGUAAACGCUUUCUGAUG |70 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | PLEKHA1 | ||||||||||||||||||||
Synonyms | TAPP1 | ||||||||||||||||||||
Description | pleckstrin homology domain containing A1 | ||||||||||||||||||||
Transcript | NM_001001974 | ||||||||||||||||||||
Other Transcripts | NM_021622 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on PLEKHA1 | |||||||||||||||||||||
3'UTR of PLEKHA1 (miRNA target sites are highlighted) |
>PLEKHA1|NM_001001974|3'UTR 1 GGCAGAAGCGCACGGAGCCTGCCTGCCTCTGCCGTCCTCAGTTTCCTTTCATGAGGCTTCTAGCCAAAGATGATAAAGGG 81 GGAAATGGTTTTTAGTGCGTATATTATACTGCCTCTTAGGTGTACTCTTTATAAGCTGGTAAACCAAGAATCTAGGGAGT 161 GGCCAAACTAAATATAATTTCTTTAAAAAAGAAAGAAAAAGGAAAAATCCAAAATATCTCAGTATCATCTGTCTGAAGCA 241 TTGTGTGTTCTCATTCGGGTGGTAACAATGTATGTGTAATATTTTTTTCTTAGTGATTTTGACAGTTTAAATGTTTAACA 321 ACTTAAAGCATTAAAAATGCTTATTAATAACTTTGGTCATTTAAAAAATGCTACAATGACTTCCTATTAAAGGTTCAATA 401 TTTACACATTCTTATTGGTTGATATTACCACATGAAATATTGCCAGACCAAGATACCTAAACTCATGATGTCTGTGGTGC 481 TGTAAAATTTATACTAAAATGTGGACTATTTTGAAATTATAACCATTTTTGATGCCCTGAATCTTGAGGTGACTTATTTT 561 GCATAGAGGATATGGATAGACCAACAGTAAGGGTTGTGGGTTATACCGGCATAGAGAAAAGAAGAAAACTAGAATTGAAA 641 CAACTGTGTCTTAGACATTTGTTTGAAAAAGCTTCATCAGGCCTTGGAGCAGTCACTGCTTTATTCCGCAAAAATTATTT 721 GGTAGGAAATTTTTGGGAGATCTGATTTTCTTATCCAAGTTTTGTAAATAGTTGTTATTTCTATATTTGGATTGGTGAAA 801 GACCTCAAGTTTATATGTAAAGACATAACTGCCCTTAGTCATGAAATTGTTGTGACCTCTACTTTTTGTCACTAATAGCC 881 TACATTCAAGTGCCTGTGTTTTTTCATCTTGTTTAGGAATGTTTTGAGATTAATGTGCTTAAAAGTCCTACGTGACTGAT 961 TTTAAACATTGTGATAAAATTAATTTTCAGTAGAATAGTTGAATGTGTTAAGATAGGATTTTATGTTAGAGATACCAGAA 1041 TGCTGGTATTCTACTACTTGTGCAATATATATGTTTTAAAAAACAAATTTGAGAATACATTTAATCATAGGGATATAGAT 1121 ATAAGCACCTCTCTAAAGAATCTTTAGTTTCCGACGTTGAATTATAGACCAGTTTGAGTAAGTACTGCTTTTTTTTTTTG 1201 GAGACGGGCTCTCGCTCTGTTGCTCAGGCTGGAGTGCAGTGGCGTGATCTCAGCTCACTACAGCCTCCACCTCGTGGGTT 1281 CAAACAGTTGTGCTGCCTCAGCTTCCCGAGTAGCTAGGATTACAGGTGCATGCCACCACACCTGGCTAATTTTTGTATTT 1361 TAGTAGAGATGGGGTTTCACCATGTTGGCCAGGCTCGTCTCGAACTCCTGACTTCAGGTGATCCACCCATCTCAGCCTCC 1441 CAAAGTGCTGGGATTACAGGCGTGAGCCACCATGCCCGGCCCATAAGTACCGTTTTTGAGGTTCAGTCTTAAACATTTGC 1521 TTTAAGAAAACAGTCTTGAATTTCACATGCTGCTATTTTTATATTTTGCCATTTTACAGTACTGTTTTGTTTTGAATTCA 1601 TGCATATCATTGAAAATTTCTCGTTTTCATTTTCTTAGATGACTTCTTGTCTGAGACAGAAAAATTTCCTACTACAGCAG 1681 TGCAGTCCAGAGGTTAAGATGTATTAGAATTATACAATATCAGTTTAAAAATCTGTATGCATAAAGAATGCACCACTCAA 1761 CTTTTTTATTCATAAGCTAATATTTTTTTAAAGTTACATTAAGATTTTTTCTCTTTTGCAGCTACATTTGAAAGTGATAG 1841 AATAAAGAGATTTTAATGAGTTATCACTTTTTCAGCTGATATATTCATTTTAATGGCTTTTTTGAAAGTTCCTTTTTCAT 1921 GAACACACCCGAGAAATCTTAAATAGACACTTTGCAATATTTAAGAACCTAATGCTGTTTAATTTTGGTACAGCTTCCAC 2001 ATTGCATGTTCACTTTAGTATTTGCAATTTGATATATTTCATGGTGGCAAAATATTAGCTCTGTTTTGGGACATTTTAAA 2081 ATAGAACTATCCTTGTTCGATAGCATAGGAAAATGTTCTGGTGATTGTCAGGGTCTCCTAATATTTATCTCAATTCTTTT 2161 ATAAGTCTATGGAAATTATTTAATTATTTTAAAACGTACACACTTTTCTTGTAAATATGTCACATCTGAGTTCAAAAAAA 2241 TTACTTTGAATACCTTAATATTTGCTGCATTTTTTTCCGTATATATAACATGTCTTCTTTCAGAATGGGAATATATGTGT 2321 GCCTCCCAACATTTACTGTTAAAGTGTGTTATCTTTATATGTCAAACTGGTTGAACACTGTAATGAGAATAAACTGCACA 2401 GAGTTTATTCTGACTTAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 59338.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000538022.1 | 3UTR | UGAAUUUCACAUGCUGCUAUUUUUAUAUUUUGCCAUUUUACAGUACUGUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
93 hsa-miR-3607-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT057680 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT058092 | EIF4G2 | eukaryotic translation initiation factor 4 gamma 2 | 2 | 4 | ||||||||
MIRT063624 | FBXO28 | F-box protein 28 | 2 | 2 | ||||||||
MIRT071884 | BTF3L4 | basic transcription factor 3 like 4 | 2 | 2 | ||||||||
MIRT079440 | FOXK2 | forkhead box K2 | 2 | 4 | ||||||||
MIRT080491 | BCL10 | B-cell CLL/lymphoma 10 | 2 | 2 | ||||||||
MIRT081214 | MIDN | midnolin | 2 | 10 | ||||||||
MIRT082786 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT082862 | ZNF543 | zinc finger protein 543 | 2 | 4 | ||||||||
MIRT099112 | FOXC1 | forkhead box C1 | 2 | 4 | ||||||||
MIRT099343 | QKI | QKI, KH domain containing RNA binding | 2 | 2 | ||||||||
MIRT100913 | CD2AP | CD2 associated protein | 2 | 2 | ||||||||
MIRT104030 | USP42 | ubiquitin specific peptidase 42 | 2 | 6 | ||||||||
MIRT130023 | QSER1 | glutamine and serine rich 1 | 2 | 2 | ||||||||
MIRT142614 | IL21R | interleukin 21 receptor | 2 | 2 | ||||||||
MIRT143477 | CHD9 | chromodomain helicase DNA binding protein 9 | 2 | 2 | ||||||||
MIRT187759 | ESYT1 | extended synaptotagmin 1 | 2 | 2 | ||||||||
MIRT200250 | EVI5 | ecotropic viral integration site 5 | 2 | 2 | ||||||||
MIRT212867 | N4BP2 | NEDD4 binding protein 2 | 2 | 2 | ||||||||
MIRT219622 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 8 | ||||||||
MIRT220244 | FAM3C | family with sequence similarity 3 member C | 2 | 6 | ||||||||
MIRT222069 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT243478 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT261690 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 2 | ||||||||
MIRT320184 | ITGB8 | integrin subunit beta 8 | 2 | 2 | ||||||||
MIRT441644 | CCNB1IP1 | cyclin B1 interacting protein 1 | 2 | 6 | ||||||||
MIRT441965 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT442175 | TRIM59 | tripartite motif containing 59 | 2 | 4 | ||||||||
MIRT442716 | TNKS | tankyrase | 2 | 2 | ||||||||
MIRT443932 | ZNF418 | zinc finger protein 418 | 2 | 2 | ||||||||
MIRT445790 | ALG13 | ALG13, UDP-N-acetylglucosaminyltransferase subunit | 2 | 2 | ||||||||
MIRT448148 | P2RY10 | purinergic receptor P2Y10 | 2 | 2 | ||||||||
MIRT463393 | ZDHHC20 | zinc finger DHHC-type containing 20 | 2 | 2 | ||||||||
MIRT463761 | YPEL2 | yippee like 2 | 2 | 2 | ||||||||
MIRT477233 | ETF1 | eukaryotic translation termination factor 1 | 2 | 2 | ||||||||
MIRT483464 | DR1 | down-regulator of transcription 1 | 2 | 6 | ||||||||
MIRT484110 | ABCD2 | ATP binding cassette subfamily D member 2 | 2 | 4 | ||||||||
MIRT487297 | SLC38A9 | solute carrier family 38 member 9 | 2 | 2 | ||||||||
MIRT501292 | RRN3 | RRN3 homolog, RNA polymerase I transcription factor | 2 | 4 | ||||||||
MIRT501343 | RNF44 | ring finger protein 44 | 2 | 4 | ||||||||
MIRT502696 | CSNK1G1 | casein kinase 1 gamma 1 | 2 | 4 | ||||||||
MIRT511075 | NIPA1 | non imprinted in Prader-Willi/Angelman syndrome 1 | 2 | 4 | ||||||||
MIRT511243 | KLHL36 | kelch like family member 36 | 2 | 6 | ||||||||
MIRT531418 | PLBD2 | phospholipase B domain containing 2 | 2 | 2 | ||||||||
MIRT536603 | IRF2 | interferon regulatory factor 2 | 2 | 2 | ||||||||
MIRT537727 | ELAVL2 | ELAV like RNA binding protein 2 | 2 | 2 | ||||||||
MIRT537985 | DPP8 | dipeptidyl peptidase 8 | 2 | 2 | ||||||||
MIRT539083 | ARNTL | aryl hydrocarbon receptor nuclear translocator like | 2 | 4 | ||||||||
MIRT547185 | PBRM1 | polybromo 1 | 2 | 2 | ||||||||
MIRT547596 | LIN28B | lin-28 homolog B | 2 | 2 | ||||||||
MIRT548188 | FOXA1 | forkhead box A1 | 2 | 2 | ||||||||
MIRT555055 | PYURF | PIGY upstream reading frame | 2 | 2 | ||||||||
MIRT557321 | HIC2 | HIC ZBTB transcriptional repressor 2 | 2 | 2 | ||||||||
MIRT557979 | FAM217B | family with sequence similarity 217 member B | 2 | 4 | ||||||||
MIRT558439 | DDIT4 | DNA damage inducible transcript 4 | 2 | 3 | ||||||||
MIRT558560 | CRLF3 | cytokine receptor like factor 3 | 2 | 4 | ||||||||
MIRT562332 | FGF2 | fibroblast growth factor 2 | 2 | 2 | ||||||||
MIRT565836 | SCML2 | Scm polycomb group protein like 2 | 2 | 2 | ||||||||
MIRT566796 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT568565 | AK4 | adenylate kinase 4 | 2 | 2 | ||||||||
MIRT572483 | PRR14L | proline rich 14 like | 2 | 2 | ||||||||
MIRT572586 | HGFAC | HGF activator | 2 | 2 | ||||||||
MIRT572876 | OPHN1 | oligophrenin 1 | 2 | 2 | ||||||||
MIRT573136 | ABT1 | activator of basal transcription 1 | 2 | 2 | ||||||||
MIRT573244 | ZBTB46 | zinc finger and BTB domain containing 46 | 2 | 2 | ||||||||
MIRT573388 | GGA2 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | 2 | 2 | ||||||||
MIRT574588 | N4BP1 | NEDD4 binding protein 1 | 2 | 2 | ||||||||
MIRT575081 | Ddit4 | DNA-damage-inducible transcript 4 | 2 | 3 | ||||||||
MIRT609077 | SMIM15 | small integral membrane protein 15 | 2 | 8 | ||||||||
MIRT619337 | RNF2 | ring finger protein 2 | 2 | 2 | ||||||||
MIRT623058 | NRXN1 | neurexin 1 | 2 | 2 | ||||||||
MIRT623307 | MARCH4 | membrane associated ring-CH-type finger 4 | 2 | 2 | ||||||||
MIRT623899 | FOXN3 | forkhead box N3 | 2 | 2 | ||||||||
MIRT625177 | GRIK4 | glutamate ionotropic receptor kainate type subunit 4 | 2 | 2 | ||||||||
MIRT630448 | GTPBP8 | GTP binding protein 8 (putative) | 2 | 2 | ||||||||
MIRT630587 | SLC9A8 | solute carrier family 9 member A8 | 2 | 2 | ||||||||
MIRT634451 | PAK6 | p21 (RAC1) activated kinase 6 | 2 | 2 | ||||||||
MIRT634727 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT635769 | PDCL3 | phosducin like 3 | 2 | 2 | ||||||||
MIRT650924 | ST6GALNAC1 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT668975 | CLSTN2 | calsyntenin 2 | 2 | 2 | ||||||||
MIRT669612 | AEBP2 | AE binding protein 2 | 2 | 2 | ||||||||
MIRT686746 | STX16 | syntaxin 16 | 2 | 2 | ||||||||
MIRT687932 | HMGN1 | high mobility group nucleosome binding domain 1 | 2 | 2 | ||||||||
MIRT691875 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT698432 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT698572 | TFDP2 | transcription factor Dp-2 | 2 | 2 | ||||||||
MIRT704500 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | 2 | 2 | ||||||||
MIRT704907 | CCDC71L | coiled-coil domain containing 71 like | 2 | 2 | ||||||||
MIRT713810 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT718300 | MOGAT1 | monoacylglycerol O-acyltransferase 1 | 2 | 2 | ||||||||
MIRT719022 | SHROOM3 | shroom family member 3 | 2 | 2 | ||||||||
MIRT723766 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|